Cargando…
ZNF703 promotes triple-negative breast cancer cells through cell-cycle signaling and associated with poor prognosis
BACKGROUND: The oncogenic drivers of triple-negative breast cancer (TNBC), which is characterized by worst prognosis compared with other subtypes, are poorly understood. Although next-generation sequencing technology has facilitated identifying potential targets, few of the findings have been transl...
Autores principales: | Zhang, Xi, Mu, Xin, Huang, Ou, Wang, Zhitang, Chen, Jialin, Chen, Debo, Wang, Gen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889678/ https://www.ncbi.nlm.nih.gov/pubmed/35236318 http://dx.doi.org/10.1186/s12885-022-09286-w |
Ejemplares similares
-
Insights into the pleiotropic roles of ZNF703 in cancer
por: Wang, Shuang, et al.
Publicado: (2023) -
Overexpression of ZNF703 facilitates tumorigenesis and predicts unfavorable prognosis in patients with cholangiocarcinoma
por: Li, Keyu, et al.
Publicado: (2016) -
Luminal Breast Cancer Cell Lines Overexpressing ZNF703 Are Resistant to Tamoxifen through Activation of Akt/mTOR Signaling
por: Zhang, Xi, et al.
Publicado: (2013) -
Nlz1/Znf703 acts as a repressor of transcription
por: Nakamura, Mako, et al.
Publicado: (2008) -
ZNF703 Overexpression may act as an oncogene in non‐small cell lung cancer
por: Baykara, Onur, et al.
Publicado: (2016)